During the past decade, Shenzhen Geno-immune Medical Institute conducted 47 clinical trials. In the 10-year time frame, 47 clinical trials started and 0 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 23 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

In terms of collaborators to trials, out of the total clinical trials conducted in "Shenzhen Geno-immune Medical Institute" #1 collaborator was "Shenzhen Children's Hospital" with 6 trials as a collaborator, "Shenzhen Hospital of Southern Medical University" with 4 trials as a collaborator, "The Seventh Affiliated Hospital of Sun Yat-sen University" with 3 trials as a collaborator, "Shenzhen Second People's Hospital" with 2 trials as a collaborator and "Shenzhen Third People's Hospital" with 2 trials as a collaborator. Other collaborators include -1 different institutions and companies that were collaborators in the rest 9 trials.

According to Clinical.Site data, the most researched conditions in "Shenzhen Geno-immune Medical Institute" are "Acute Myeloid Leukemia" (3 trials), "B Cell Malignancies" (3 trials), "Cancer" (3 trials), "Ovarian Cancer" (3 trials) and "Solid Tumor" (3 trials). Many other conditions were trialed in "Shenzhen Geno-immune Medical Institute" in a lesser frequency.

Most popular intervention types in "Shenzhen Geno-immune Medical Institute" are "Biological" (40 trials) and "Genetic" (8 trials). Other intervention types were less common.

The name of intervention was led by "Antigen-specific T cells CART/CTL and DCvac" (2 trials), "Gene-modified autologous stem cells" (2 trials), "4SCAR T cells" (1 trials), "4SCAR-276" (1 trials) and "4SCAR-CD22/CD123/CD38/CD10/CD20/TSLPR" (1 trials). Other intervention names were less common.

The vast majority of trials in "Shenzhen Geno-immune Medical Institute" are 42 trials for "All" genders, 5 trials for "Female" genders and 1 trials for "Male" genders.

Currently, there are NaN active trials in "Shenzhen Geno-immune Medical Institute". undefined are not yet recruiting, 20 are recruiting, undefined are Active, not recruiting, and 1 are Enrolling by invitation. In total, there were undefined completed trials in Shenzhen Geno-immune Medical Institute, 1 suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Shenzhen Geno-immune Medical Institute, 43 "Phase 1" clinical trials were conducted, 36 "Phase 2" clinical trials and 0 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 5 trials that are defined as “Not Applicable".